BDBM608372 (Z)-15-chloro-96-fluoro-13,21,23,61- tetramethyl-11H,21H,61H-10-oxa-4,8-dithia- 1(4,1)-indola-2(4,5),6(3,5)-dipyrazola-9(3,1)- naphthalenacyclotridecaphane-12-carboxylic acid::US11691989, Compound 28

SMILES Cc1nn(C)c2CSCc3cc(CSc4cc(OCCCn5c(C(O)=O)c(C)c6c(-c12)c(Cl)ccc56)c1ccc(F)cc1c4)n(C)n3

InChI Key InChIKey=GNSDFCGUCYQSDV-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 608372   

TargetInduced myeloid leukemia cell differentiation protein Mcl-1 [171-323](Human)
Ascentage Pharma (Suzhou)

US Patent
LigandPNGBDBM608372(US11691989, Compound 28 | (Z)-15-chloro-96-fluoro-...)
Affinity DataIC50: 14nMAssay Description:The relative binding potency of representative Compounds of the Disclosure was determined by a fluorescence polarization (FP) assay. The method used ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2023
Entry Details
Go to US Patent